AC Immune SA (ACIU:NASDAQ) closed at $2.44 on November 9, 2026, up 9.42% on the day. The stock trades 37.4% below its 52-week high of $3.90 and 21.1% above its 52-week low of $2.02. Over the past year, it lost 32.4%. AC Immune SA is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since November 7, 2025, ACIU closed higher on 116 days (46%). Its best day was December 11, 2025 (+15.41%) and its worst was December 17, 2025 (-10.64%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 2 times.
AC Immune SA is a biopharmaceutical company. It is engaged in leveraging its two proprietary technology platforms to discover, design and develop novel, proprietary medicines for treatment of neurodegenerative diseases.
Find more stocks like ACIU with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.